![]()
A) <110 mmHg B) <80 mmHg C) <90 mmHg D) <100 mmHg
A) 0.14% B) 0.01% C) 0.50% D) 1.4%
A) 50% B) 69% C) 96% D) 16%
A) 1000 μg/L B) 50 μg/L C) 100 μg/L D) 500 μg/L
A) Age multiplied by 5 μg/L B) Age multiplied by 10 μg/L C) Age plus 500 μg/L D) Age divided by 10 μg/L
A) 5% to 15% B) 16% to 47% C) 69% to 84% D) 50% to 60%
A) CT pulmonary angiography B) Leg ultrasound C) Erythrocyte sedimentation rate D) Right heart catheterization
A) It is less accurate than a blood count B) It cannot rule out PE C) It is rarely available D) It is highly invasive
A) It is much more expensive B) It is less sensitive C) It is non-inferior D) It is significantly inferior
A) It may identify other lung disorders B) It has 100% specificity C) It is always done before D-dimer D) It requires right heart catheterization
A) 69% B) 83% C) 96% D) 50%
A) It has 0% specificity B) It has limited sensitivity C) It is too expensive D) It requires contrast agent
A) To provide evidence for the need for imaging B) To definitively confirm PE C) To replace the need for CTPA entirely D) To measure lung function
A) D-dimer only B) Full blood count and clotting status C) Troponin only D) Blood pressure only
A) Incorporation bias B) Selection bias C) Age bias D) Measurement bias
A) 69% B) 50% C) 96% D) 83%
A) Factor V Leiden mutation B) Red blood cell count C) Vitamin D levels D) Blood glucose levels
A) Between 100 and 110 beats per minute B) Less than 100 beats per minute C) Greater than 120 beats per minute D) Exactly 150 beats per minute
A) Exactly 90% B) More than 94% C) Less than 80% D) Between 85% and 90%
A) No history of surgery B) Estrogen use C) No leg swelling D) No coughing up blood
A) As a confirmatory test B) To replace the need for clinical history C) To diagnose lung cancer D) As a screening test for everyone
A) 96% B) 41% C) 80% D) 10%
A) Hospital policy only B) Clinical reasoning C) Patient preference alone D) The time of day
A) No leg swelling B) A history of trauma in the last year C) Age less than 50 D) No previous blood clots
A) Iliofemoral DVT B) Distal calf DVT C) Superficial venous thrombosis D) Portal vein thrombosis
A) Young men without significant risk factors B) Children with genetic disorders C) Elderly women with cancer D) Athletes with chronic dehydration
A) Arterial thrombosis B) Pulmonary hypertension syndrome C) Chronic venous insufficiency D) Venous thromboembolism
A) The hypercoagulable model B) Virchow's triad C) The clotting cascade D) The VTE framework
A) Dental surgery B) Ocular surgery C) Orthopedic surgery at or below the hip D) Tonsillectomy
A) Protein C deficiency B) Factor V Leiden C) Antiphospholipid syndrome D) Protein S deficiency
A) Paroxysmal nocturnal hemoglobinuria B) Nephrotic syndrome C) Protein C deficiency D) Antiphospholipid syndrome
A) They stimulate procoagulant secretion B) They decrease the blood viscosity C) They cause systemic dehydration D) They cause endothelial injury
A) Prolonged bed rest B) Frequent exercise C) Low altitude living D) High-fiber diet
A) D-dimer B) Liver function test C) White blood cell count D) Troponin test
A) Acetaminophen B) Warfarin C) Ibuprofen D) Aspirin
A) Lung transplant B) Blood transfusion C) Temporary vena cava filter D) Chest tube insertion
A) Cyanosis B) Hemoptysis C) Dyspnea D) Tachypnea
A) Direct-acting oral anticoagulants B) Warfarin C) Heparin D) Tissue plasminogen activator
A) Nearly 90% B) About 15% C) 50% D) Less than 1%
A) Philip Steven Wells B) The PIOPED investigators C) The Geneva rule group D) The 64-slice MDCT researchers
A) Low probability B) Moderate probability C) High probability D) Confirmed PE
A) 2.0 points B) 3.0 points C) 1.0 points D) 1.5 points
A) 97.4% B) 21.9% C) 1.0% D) 5.0%
A) PIOPED recommendation B) Geneva rule C) Wells score D) PERC rule
A) Patients with high blood pressure B) Patients with chronic obstructive pulmonary disease C) Elderly patients D) Pregnant patients
A) Chest X-ray B) Fluoroscopy C) SPECT D) Planar two-dimensional imaging
A) Left bundle branch block B) ST elevation in V5-V6 C) S1Q3T3 D) Prolonged PR interval
A) Complete heart block B) Inverted T waves in V1-V4 C) Sinus tachycardia D) Atrial fibrillation
A) Sinus bradycardia B) QRS narrowing C) Atrial fibrillation D) Normal sinus rhythm
A) Antibiotic therapy B) Beta-blocker administration C) Diuretic monotherapy D) Thrombolysis
A) Creatinine B) Brain natriuretic peptide C) C-reactive protein D) White blood cell count
A) Determining lung volume B) Diagnosing pneumonia C) Checking for pleurisy D) Prognosis assessment
A) Homan's sign B) McConnell's sign C) Virchow's sign D) Trousseau's sign
A) 50% B) 77% C) 94% D) 25%
A) Yes B) Only if they are asymptomatic C) Only if they are under 18 years old D) No
A) Hemoglobin B) Troponins C) Albumin D) Glucose
A) Bed rest and elevation B) Surgical removal of the embolus C) Anticoagulant therapy D) Long-term aspirin therapy
A) Heparin B) Aspirin C) Warfarin D) Fondaparinux
A) LMWH B) Warfarin C) Aspirin D) Dabigatran
A) 10–12 months B) 1 month C) 1 week D) 3–6 months
A) 2 years B) 10 years C) 6 months D) 1 month
A) Increased appetite B) Itching C) Mild headache D) Hypotension
A) 5% B) 26% C) 10% D) 50%
A) Bristol Royal Infirmary B) London General Hospital C) Cambridge Medical Center D) Oxford University Hospital
A) Allergies B) COPD C) Type 1 diabetes D) Thyroid disease
A) The patients were all children B) The sample size was too large C) Old technology detected only severe PEs D) The data was fabricated
A) High blood glucose B) Low hemoglobin C) Elevated cardiac enzymes D) Increased white blood cell count
A) Fibrinolysis B) Surgery C) Osmosis D) Radiation
A) 10 B) 15 C) 5 D) 11
A) 40,000 B) 10,000 C) 250,000 D) 100,000 |